Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-8-28
pubmed:abstractText
Thyroid glands affected by Graves' disease (GD) show striking leukocytic infiltration, mainly by T-cells. The mechanisms by which the various leukocytes are maintained in the thyroid are unknown. Growth-regulated oncogene-alpha (GRO-alpha) in interaction with its receptor CXCR2 is a chemoattractant for both T-cells and neutrophils and may be one of the chemokines involved in the cell maintenance. GRO-alpha and CD18 mRNA as a marker of leukocytic infiltration were quantified in thyroid tissue using competitive RT-PCR. We found very high GRO-alpha mRNA levels in all thyroid tissues. In GD patients (n=16), the GRO-alpha mRNA did not correlate with the CD18 mRNA level or thyroid peroxidase and TSH-receptor antibodies in patients' sera. In thyroid autonomy (n=10), the GRO-alpha mRNA levels were significantly lower in autonomous single adenomas compared with the corresponding normal tissue. In order to define the cellular source of GRO-alpha mRNA and protein, we examined various thyroid-derived cells. Thyrocytes, thyroid-derived leukocytes and fibroblasts showed basal GRO-alpha mRNA and protein expression, which was remarkably upregulated by different stimuli in vitro. The expression of GRO-alpha by thyroid carcinoma cell lines confirms that thyrocytes may actually produce GRO-alpha. As shown by flow cytometry and immunohistology, CD68+ monocytes/macrophages are the only cell population strongly expressing CXCR2 in the thyroid.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-0795
pubmed:author
pubmed:issnType
Print
pubmed:volume
170
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
513-20
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11524231-Adenoma, pubmed-meshheading:11524231-Adult, pubmed-meshheading:11524231-Cell Culture Techniques, pubmed-meshheading:11524231-Chemokine CXCL1, pubmed-meshheading:11524231-Chemokines, CXC, pubmed-meshheading:11524231-Chemotactic Factors, pubmed-meshheading:11524231-Female, pubmed-meshheading:11524231-Gene Expression Regulation, pubmed-meshheading:11524231-Graves Disease, pubmed-meshheading:11524231-Growth Substances, pubmed-meshheading:11524231-Humans, pubmed-meshheading:11524231-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:11524231-Macrophages, pubmed-meshheading:11524231-Male, pubmed-meshheading:11524231-Middle Aged, pubmed-meshheading:11524231-Neoplasm Proteins, pubmed-meshheading:11524231-RNA, Messenger, pubmed-meshheading:11524231-Receptors, Interleukin-8B, pubmed-meshheading:11524231-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:11524231-Thyroid Diseases, pubmed-meshheading:11524231-Thyroid Gland, pubmed-meshheading:11524231-Thyroid Neoplasms, pubmed-meshheading:11524231-Tumor Cells, Cultured
pubmed:year
2001
pubmed:articleTitle
GRO-alpha in normal and pathological thyroid tissues and its regulation in thyroid-derived cells.
pubmed:affiliation
Department of Surgery, Institute of Anatomy, University of Leipzig, Germany. ausg@medizin.uni-leipzig.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't